Ania Jastreboff, MD, PhD
Associate Professor of Medicine (Endocrinology); Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management; Medical Director, Yale Stress Center
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Ania M. Jastreboff, MD, PhD is an Associate Professor in Medicine and Pediatrics at Yale School of Medicine. She serves as the director of the Yale Obesity Research Center (Y-Weight) and the co-director of the Yale Center for Weight Management. She is trained in both adult endocrinology and pediatric endocrinology, is an obesity medicine physician-scientist, and an international leader in research and clinical application of anti-obesity pharmacotherapeutics. Her work has included working to develop Obesity Clinical Practice Guidelines (AACE/ACE 2016), serving on the Board of Directors for the American Board of Obesity Medicine, educating the next generation of Obesity Medicine physicians by teaching at national and international obesity treatment courses, and conducting cutting-edge clinical-translational obesity research. Her research includes large, multi-center clinical outcomes trials using novel anti-obesity pharmacotherapeutics and studies examining the neurobiology underlying obesity and mechanisms of anti-obesity medications (supported by the NIH/NIDDK). Recently, she has served as lead author for trials investigating potential novel nutrient-stimulated hormone-based therapies for obesity including dual hormone receptor agonist tirzepatide (NEJM) a novel GIP/GLP-1 receptor agonist (Jastreboff, et al., NEJM, 2022) and triple hormone receptor agonist retatrutide (NEJM) a novel GIP/GLP-1/Glucagon receptor agonist (Jastreboff, et al., NEJM, 2023). Dr. Jastreboff thoughtfully advocates for compassionate care for patients with obesity and was recently interviewed Oprah.
Videos of Dr. Jastreboff and colleagues from the NEJM about:
- What causes obesity: https://www.nejm.org/doi/full/...
- Supporting patients with obesity: https://www.nejm.org/doi/full/...
- Medications and surgery for obesity treatment: https://www.nejm.org/doi/full/...
Yale video with Dr. Jastreboff about anti-obesity medications and the biology of obesity.
Podcast (Yale Talk) with the president of Yale University, Dr. Peter Salovey, speaking with Dr. Jastreboff.
Clinically, Dr. Jastreboff specializes in sophisticated use of anti-obesity medication combinations to help patients reach their weight and health goals.
Education & Training
- Student - Yale Advanced Emerging LeadersYale University (2023)
- Yale Public Voices FellowshipYale University (2022)
- Clinical ScholarYale University School of Medicine (2013)
- YCCI Clinical Research ScholarYale School of Medicine (2013)
- PhDYale University Graduate School of Arts and Sciences, Investigative medicine (2012)
- Neuromanaging in PsychiatryYale School of Medicine (2011)
- Postdoctoral FellowshipYale University (2011)
- Postdoctoral FellowshipYale University (2011)
- Food Policy and ScienceYale University (2010)
- Nutrition and Chronic DiseaseYale University (2009)
- Learning to Mentor the next generation of scientistsYale School of Medicine (2009)
- Chief ResidentUniversity of Maryland (2006)
- ResidencyUniversity of Maryland School of Medicine (2006)
- InternUniversity of Maryland (2003)
- MDUniversity of Maryland at Baltimore (2002)
- BABucknell University, Art History/Major, Music/Minor. Magna cum laude (1998)
Activities
- Once-weekly Triple Receptor (GIP/GLP-1/Glucagon) Agonist Retatrutide (LY3437943): Efficacy and Safety in a 48-week Obesity Phase 2 TrialVenice, Veneto, Italy 202431st European Congress on Obesity (ECO 2024)
- Nutrient-stimulated Hormone-based pharmacotherapy for the treatment of obesity: Sparks from the pipeline!New York, NY, United States 2024Keynote Speaker: Obesity Etiology, Prevention, and Treatment
- "From Awareness to Action: How do We Treat Adolescent Obesity" and "Once -Weekly Triple Receptor (GIP/GLP-1/Glucagon) Agonist Retatrutide (LY3437943): Efficacy and Safety in a 48-Week Obesity Phase 2 Trial" and "Different Targets for Different Patients"Venice, Veneto, Italy 202431st European Congress on Obesity (ECO)
- "Once-weekly Triple Receptor (GIP/GLP-1/Glucagon) Agonist Retatrutide (LY3437943): Efficacy and Safety in a 48-week Obesity Phase 2 Trial" and "Retatrutide T2D: Efficacy and Safety Results of the 36-week T2D Phase 2 Trial"Berlin, BE, Germany 202458th Jahrestagung
- Anti-obesity medications for the treatment of obesity: the importance of optimizing health - muscle mattersNew York, NY, United States 2024Scholar Rock
- Anti-obesity medications for the treatment of obesity: Sparks from the pipelineWashington, DC, United States 2024National Academy of Medicine Emerging Leaders Forum
- Nutrition-stimulated hormone-based medication for obesity treatment: Sparks from the pipelineSan Diego, CA, United States 2024AACR Annual Meeting
- Transformation: What is to come in the pipeline of anti-obesity medicationsVirtual 2024Roundtable of Obesity Solutions
- Treating adolescent obesity: A focus on pharmacotherapySaint Marks, Saint John, Barbados 2024Obesity Symposium: Bridging the Gap
- "Once-weekly Triple Receptor (GIP/GLP-1/Glucagon) Agonist Retatrutide (LY3437943): Efficacy and Safety in a 48-week Obesity Phase 2 Trial" and "Retatrutide T2D: Efficacy and Safety Results of the 36-week T2D Phase 2 Trial"Aussonne, Occitanie, France 202450th Congres Annuel
- Obesity pathophysiologyVirtual 2024Advanced Therapeutics in Pediatric Obesity
- Nutrient-stimulated hormone-based medication for obesity treatmentOrlando, FL, United States 2024Advent Health Translational Research Institute
- Anti-obesity medications for the treatment of obesity: Sparks from the pipelineLedyard, CT, United States 2024Obesity Summit 2024
- Nutrient-stimulated hormone-based medications for obesity treatmentLos Angeles, CA, United States 202320th World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease
- Tirzepatide reduces body weight across BMI categories: analysis from the SURMOUNT-1 studySendai, Miyagi, Japan 202344th Annual Meeting
- SELECT trial discussantPhiladelphia, PA, United States 2023AHA Scientific Sessions: Opening Session
- Pathophysiology of obesity and rationale for anti-obesity pharmacotherapyBethesda, MD, United States 2023Pharmacotherapy for Obesity in Children and Adolescents: State of the Science, Research Gaps, and Opportunities
- Sex, Age and BMI Predict Weight Loss Response to the GIP/GLP-1/Glucagon Receptor Agonist RetatrutideDallas, TX, United States 2023Obesity week 2023
- Parenting Mindfully to Address Stress and Family Food Choices Reduces Early Childhood Obesity RiskDallas, TX, United States 2023Obesity Week 2023
- The physiology of obesity and rationale for anti-obesity pharmacotherapyWashington, DC, United States 2023AAP Annual Meeting
- Sex, age and BMI predict weight loss response to GIP/GLP-1/Glucagon receptor agonist retatrutideDallas, TX, United States 2023Obesity Week
- SURMOUNT-3: Study design and baseline characteristicsDallas, TX, United States 2023Obesity Week
- Sparks from the pipeline: What is to come in the world of anti-obesity medications (Key Lecture)Dallas, TX, United States 2023Obesity Society Week
- Once-weekly triple receptor (GIP/GLP-1/Glucagon) agonist retatrutide (LY3437943): Efficacy and safety in a 48-week obesity phase 2 trialHamburg, HH, Germany 2023European Association for the Study of Diabetes Meeting
- "Once-weekly Triple Receptor (GIP/GLP-1/Glucagon) Agonist Retatrutide (LY3437943): Efficacy and Safety in a 48-week Obesity Phase 2 Trial" and "Retatrutide T2D: Efficacy and Safety Results of the 36-week T2D Phase 2 Trial"Hamburg, HH, Germany 202359th Annual Meeting
- Unmet needs in obesity care: CagriSema and tirzepatide and the importance of retention in clinical trials (Keynote)Virtual? 2023REDEFINE-4 Investigator Meeting
- Anti-obesity medications: The future is now!Philadelphia, PA, United States 2023Obesity Symposium
- Tirzepatide for treatment of obesity and a glimpse of the pipelineBethesda, MD, United States 2023Obesity Research Task Force Symposium on Medications to Treat Obesity: Past, Present and Future
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 Pre-Specified AnalysisBelfast, Northern Ireland, United Kingdom 2023UK Congress on Obesity (UKCO 2023)
- Obesity pathophysiologyVirtual? 2023Obesity 2023
- Anti-obesity pharmacotherapy: The future is now! and The nuts and bolts of anti-obesity pharmacotherapyKiawah Island, SC, United States 202331st Annual Primary Care Conference
- Retatrutide obesity: Efficacy and safety results of the 48-week obesity phase 2 trial and Clinical implications of nutrient-stimulated hormone-based pharmacotherapySan Diego, CA, United States 202383rd Scientific Sessions
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 Pre- Specified AnalysisRio de Janeiro, RJ, Brazil 2023XX Congresso Brasileiro de Obesidade e Sindrome Metabolica
- Overcoming barriers to use of anti-obesity pharmacotherapyBoston, MA, United States 202336th Course in Obesity Medicine
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 xBerlin, BE, Germany 202314th Annual Scientific Meeting
- Nutrient-stimulated hormone-based therapeutics in development for the treatement of obesity: a focus on orforglipron and retatrutideDublin, D, Ireland 202330th European Congress on Obesity
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 Pre-Specified AnalysisBerlin, BE, Germany 202357th Jahrestagung
- "Nutrient-stimulated hormone-based therapeutics in development: A focus on orforglipron and retatrutide" and "Tirzepatide for the Treatment of Obesity: the SURMOUNT-1 Clinical Trial"Dublin, D, Ireland 202330th European Congress on Obesity
- Treating adolescent obesity (Keynote)Virtual 2023STEP-YOUNG Investigator Meeting
- Medications to treat obesityVirtual 2023Your Weight Matters 2023
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 Pre-Specified AnalysisLiverpool, England, United Kingdom 2023Annual Professional Conference 2023
- Anti-obesity medication: The future is now! and Novel anti-obesity medicationsSydney, NSW, Australia 2023Annual Meeting: Diabetes and Obesity Management 2023
- Anti-obesity pharmacotherapy for the treatment of adolescent obesitySydney, NSW, Australia 2023Grand Rounds
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 Pre-Specified AnalysisValencia, VC, Spain 2023XXXIV Congreso
- Anti-obesity medication: The future is now!Houston, TX, United States 2023SURMOUNT-MMO Meeting
- Obesity PathologyVirtual 2023Advanced Therapeutics in Pediatric Obesity
- Anti-obesity pharmacotherapy: The future is now! and The nuts and bolts of anti-obesity pharmacotherapyWailua, HI, United States 202311th Annual Primary Care Winter Conference
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 Pre-Specified AnalysisDubai, Dubai, United Arab Emirates 202313th Emirates Diabetes & Endocrine Congress (EDEC 2023)
- Anti-obesity pharmacotherapy: The future is now!Los Angeles, CA, United States 2023CTSI Distinguished Speaker Series
- Anti-obesity pharmacotherapy: The future is now!Virtual grand rounds 2023Grand Rounds
- Tirzepatide for obesity treatmentPresented virtually 2022Heart, Diabetes and Kidney - Make the Link meeting in Cairo, Egypt
- Anti-obesity pharmacotherapy: The future is now!Merida, Yuc., Mexico 2022Annual Sociedad Mexicana de Nutricion y Endocrinolgia Meeting
- Anti-obesity pharmacotherapy: The future is now!New Haven, CT, United States 202253rd Annual Symposium
- Treating children and adolescents with obesityVirtual 2022Obesity Forum 2022
- Anti-obesity pharmacotherapy: The Future is now! and The nuts and bolts of anti-obesity pharmacotherapyDuck Key, FL, United States 202213th Annual Essentials in Primary Care Fall Conference
- The Future of Anti-obesity PharmacotherapySan Diego, CA, United States 2022Presidential Plenary- Obesity week
- Tirzepatide Reduces Body Weight Across BMI Categories: a SURMOUNT-1 Pre-Specified AnalysisSan Diego, CA, United States 2022Obesity Week 2022
- Anti-obesity pharmacotherapy: The future is now!Bethesda, MD, United States 2022Health Equity Workshop
- SURMOUNT-1: Efficacy and Safety DataStockholm, Stockholm County, Sweden 202258th Annual Meeting
- Anti-obesity pharmacotherapy for adolescent obesityTaipei, Taiwan 2022TSPGHAN
- Anti-obesity pharmacotherapy: The future is now!Indianapolis, IN, United States 2022Company presentation
- Anti-obesity pharmacotherapy: The future is now!Ridgefield, CT, United States 2022Company Presentation
- GLP-1 Receptor Agonists and BeyondVirtual Webinar 2022Metabolic Surgery Webinar
- Overcoming barriers to use of anti-obesity pharmacotherapy. Also Anti-Obesity Pharmacotherapy for Adolescent ObesityBoston, MA, United States 202235th Annual Course in Obesity Medicine: Treating Obesity 2022
- SURMOUNT-1: Results, Primary and Secondary OutcomesNew Orleans, LA, United States 2022ADA Scientific Symposium
- GLP-1 receptor agonists and beyondNew Orleans, LA, United States 202282nd ADA Scientific Sessions
- Parenting Stress and Drinking to Cope Association with Early Childhood Risk BehaviorsWhere was this? 2022Research Society on Alcoholism.
- Anti-obesity pharmacotherapyDanbury, CT, United States 202237th Annual Joseph L. Belsky Research Day
- Anti-obesity pharmacotherapyVirtual. Modules available in English, French, Spanish & Portuguese 2022World Obesity Federation
- Obesity pathophysiologyVirtual due to Covid 2022Obesity Etiology, Prevention, and Treatment
- Obesity pharmacotherapy after bariatric surgeryVirtual due to Covid 2022Obesity LIVE
- Parenting Stress and Drinking to Cope Association with Early Childhood Risk BehaviorsLas Vegas, NV, United States 2022ACTS Meeting
- Anti-obesity pharmacotherapy for the treatment of adolescents with obesityVirtual 2022Obesity Summit - Dubai
- Anti-obesity pharmacotherapy: The future is now!Baton Rouge, LA, United States 2022William Hansel Visiting Scientist Seminar
- Case-based approach: Caring for children and adolescents with obesityVirtual interactive webinar 2022Webinar on Pediatric Obesity
- Obesity PathophysiologyVirtual Interactive 2022Advanced Therapeutics in Pediatric Obesity
- Anti-obesity pharmacotherapy: The future is now!Nashville, TN, United States 2022Endocrinology Grand Rounds
- Anti-obesity pharmacotherapy: The future is now!Atlanta, GA, United States 2022Endocrinology Grand Rounds
- Targeting obesity pathophysiology: Lessons learned from monogenetic obesityTucson, AZ, United States 2022AACE Obesity Conference
- Advancing Interventions for Adult Obesity to Promote Health Equity: State of the Science and ResearchMaryland City, MD, United States 2022NIH workshop Health Equity
- Strategies in the management of weight maintenance and regainVirtual due to Covid 2021Analyzing the Pathophysiology of Obesity and Its Impact on Individuals
- Key concepts in treating obesity as a disease: A focus on pharmacological interventionsLos Angeles, CA, United States 202119th World Congress Insulin Resistance Diabetes Cardiovascular Disease
- Anti-obesity pharmacotherapy for adolescent obesityVirtual due to Covid 2021AACE Middle East Meeting: Dubai
- Anti-obesity pharmacotherapy: The future is now!New York, NY, United States 2021Endocrinology Grand Rounds
- Stress interacts with heart rate variability to predict child dysregulation in parents with obesityVirtual due to Covid 2021Obesity Week 2021
- Anti-obesity pharmacotherapy: The future is now!Chapel Hill, NC, United States 2021Endocrinology Grand Rounds
- Pharmacotherapy for treating adolescents with obesityVirtual due to Covid. 2021Webinar (Live) Pediatric Obesity Conference
- Anti-obesity pharmacotherapy for adolescents with obesityVirtual due to Covid 202159th Annual Meeting
- Overcoming barriers to obesity therapyVirtual due to Covid 202173rd Annual Clinical Endocrinology Update (CEU) Meeting
- Anti-obesity pharmacotherapy for adolescent obesity: Where are we now? Where are we going?Minneapolis, MN, United States 2021Pediatric Grand Rounds
- Teenage brains on sugar: neural response to monosaccharide ingestion in adolescent obesityMinneapolis, MN, United States 2021Scientific Seminar
- Pharmacotherapy for treating adolescents with obesityChicago, IL, United States 2021Overcoming Obesity 2021
- Treating children and adolescents with obesityVirtual due to Covid 2021Obesity Forum 2021
- Current pharmacotherapy for obesityVirtual due to Covid. 2021Scientific Session
- Two lectures: Obesity pharmacotherapy and Overcoming barriers to use of anti-obesity pharmacotherapy, and three workshopsBoston, MA, United States 202134th Annual Blackburn Course in Obesity Medicine
- Pharmacotherapy for the treatment of adolescent obesity: Where are we now? Where are we going?Rio de Janeiro, RJ, Brazil 202134th Brazilian Congress of Endocrinology and Metabolism
- Pharmacotherapy for the treatment of adolescents with obesity and Combination pharmacotherapy for the treatment of individuals with obesityOriginally scheduled to take place in Santiago, Chile. Virtual due to Covid. 20212nd International Program: Medical and Surgical Treatment of Obesity
- Pharmacologic anti-obesity therapiesVirtual due to Covid 2021Scientific Workshop on the Management of Obesity and Chronic Kidney Disease
- Pharmacological treatment of obesityVirtual due to Covid 2021Executive Education Program in Obesity Care
- Association between parenting stress and fast-food consumption among parents and toddlersVirtual due to covid 2021Annual Meeting
- Obesity physiology and geneticsVirtual due to Covid 2021Obesity Etiology, Prevention, and Treatment
- Pharmacological treatment of adolescents with obesity: Where are we now? Where are we going?Virtual due to Covid 2021ENDO 2021 Annual Meeting
- Obesity PathophysiologyVirtual due to Covid 2021Advanced Therapeutics in Pediatric Obesity
- Association of poor access to care with new diagnosis of chronic hypertension postpartumVirtual due to covid 2021Annual Meeting
- Pharmacotherapy for the treatment of adolescent obesity: Where are we now? Where are we going?Virtual, due to Covid 202034th Brazilian Congress of Endocrinology and Metabolism
- Anti-obesity pharmacotherapy and mentoring for junior faculty through the promotion processVirtual due to Covid 2020Obesity Week 2020
- Treating children and adolescents with obesityVirtual due to Covid. 2020Obesity Forum 2020
- Obesity and viral infectionsVirtual due to Covid 2020Presidential Symposium
- Anti-obesity pharmacotherapyVirtual due to Covid 2020Webinar Series: The Obesity Epidemic
- Using anti-obesity pharmacotherapy for the treatment of patients with obesity and type 2 diabetesVirtual due to covid. 2020Endocrinology Fellow Series
- Obesity Pharmacotherapy Workshops and Meet the ExpertBoston, MA, United States 2020Obesity Pharmacotherapy Workshops and Meet the Expert
- GLP-1 analogue effects on neural responses to high-fructose corn syrup and eating behavior in obesityVirtual due to Covid 202080th Scientific Sessions
- Obesity PharmacotherapyBoston, MA, United States 2020Obesity Pharmacotherapy
- Overcoming barriers to use of anti-obesity pharmacotherapyBoston, MA, United States 2020Overcoming barriers to use of anti-obesity pharmacotherapy
- The best strategy for diabetes remission using obesity treatments is... pharmacotherapyOriginally slated to be held in Chicago, IL. Virtual due to Covid. 2020The best strategy for diabetes remission using obesity treatments is... pharmacotherapy
- Treating childhood and adolescent obesity during the Covid-19 crisisVirtual due to Covid 2020World Obesity Live - Children, Obesity, and Covid-19
- Pharmacological treatment of adolescents with obesitySan Francisco, CA, United States 2020Pharmacological treatment of adolescents with obesity
- Pharmacotherapy for the treatment of adolescents with obesityCleveland, OH, United States 2020Pharmacotherapy for the treatment of adolescents with obesity
- Pharmacotherapy for the treatment of adolescents with obesity: Where are we now? Where are we going?Worcester, MA, United States 2020Pediatric Grand Rounds
- Presidential Symposium: Obesity and Viral InfectionNew Haven, CT, United States 2020The Obesity Society’s Obesity Week 2020
- Effects of exenatide and cocaine on plasma levels of GLP-1, insulin, and amylin among human cocaine usersOrlando, FL, United States 2019Annual Conference
- Hold ‘em or Draw? Pharmacological Treatment on Adolescents with ObesityLas Vegas, NV, United States 2019Hold ‘em or Draw? Pharmacological Treatment on Adolescents with Obesity
- Obesity PharmacotherapyBoston, MA, United States 2019Obesity Pharmacotherapy
- Overcoming Barriers to use of Anti-Obesity PharmacotherapyBoston, MA, United States 2019Overcoming Barriers to use of Anti-Obesity Pharmacotherapy
- Two lectures (Obesity pharmacotherapy and Overcoming barriers to use of anti-obesity pharmacotherapy), three Workshops and Meet the ExpertBoston, MA, United States 201932nd Annual Blackburn Course in Obesity Medicine: Treating Obesity 2019
- Teenage Brains on Sugar: Neural Response to Monosaccharide Ingestion in Adolescent ObesityNew York, NY, United States 2019Diabetes & Endocrinology Grand Rounds
- Obesity Pathophysiology: the role of the brainNew York, NY, United States 2019Obesity Etiology, Prevention, and Treatment Course
- Obesity is Highly Prevalent Among Patients Admitted to an Emergency Department Chest Pain Observation UnitLas Vegas, NV, United States 2019National Meeting
- Investigating GLP-1 Agonism for Blocking Cocaine Euphoria and Self-AdministrationOrlando, FL, United States 201950th Annual Conference
- Neuroimaging and Modulation in Obesity and Diabetes ResearchBethesda, MD, United States 2019Neuroimaging and Modulation in Obesity and Diabetes Research
- Does Hyperinsulinemia in Obesity Elicit Brain Responses that Provoke Greater Motivation for Food?Bethesda, MD, United States 2019Workshop: Neuroimaging and Modulation in Obesity and Diabetes Research
- Obesity Is Associated with Reduced 11-beta-Hydoxysteroid Dehydrogenase Type I Levels in the Human BrainBethesda, MD, United States 2019Workshop: Neuroimaging and Modulation in Obesity and Diabetes Research
- Mindfulness based stress reduction for older couples with metabolic syndromeVancouver, BC, Canada 2019Annual Meeting
- Characterizing Obesity and Outcomes among Emergency Department Patients Admitted to a Chest Pain Observation UnitWorcester, MA, United States 2019New England Regional Meeting
- Treating patients with diabetes and obesity: the role of bariatric surgery and pharmacotherapyNew London, CT, United States 2019Annual Meeting
- Pharmacologic Treatment of ObesityLas Vegas, NV, United States 2019Executive Education Program in Obesity Care – Part 2
- Treating patients with Diabetes and Obesity: the Role of Bariatric Surgery and PharmacotherapyLedyard, CT, United States 2019Treating patients with Diabetes and Obesity: the Role of Bariatric Surgery and Pharmacotherapy
- Obesity Is Highly Prevalent among Patients Admitted to an Emergency Department Chest Pain Observation UnitLas Vegas, NV, United States 2019Obesity Is Highly Prevalent among Patients Admitted to an Emergency Department Chest Pain Observation Unit
- Pharmacologic Treatment of ObesityPhoenix, AZ, United States 2018Novo Nordisk Obesity Educators
- Hyperinsulinemia Invokes Greater Cerebral Blood Flow in Reward and Motivation Regions in ObesityOrlando, FL, United States 201878th Scientific Sessions
- Reduction of 11β-hydroxysteroid dehydrogenase type 1 enzyme levels with increasing body mass index: A Brain PET imaging studyPhiladelphia, PA, United States 2018SNMMI
- Special Considerations in Use of Hybrid Closed LoopCharlotte, NC, United States 2018Hybrid Closed Loop Center of Excellence Program
- Obesity Pharmacotherapy Workshops and Meet the ExpertBoston, MA, United States 201831st Annual Blackburn Course in Obesity Medicine
- Severe Hypercalemia and acute pancreatitis in a postpartum womanBoston, MA, United States 201827th Annual Meeting
- Obesity is associated with reduced 11β-Hydroxysteroid Dehydrogenase Type 1 levels in the Human BrainChicago, IL, United States 2018Annual Meeting - ENDO 2018
- Obesity, Physiology and GeneticsNew York, NY, United States 2018Obesity Etiology, Prevention, and Treatment course
- Special Considerations in Use of Hybrid Closed LoopFort Lauderdale, FL, United States 2018Hybrid Closed Loop Center of Excellence Program
- Teenage Brains of Sugar: Neural Responses to Monosaccharide Ingestion in Adolescent ObesityIowa City, IA, United States 2018Frontiers in Obesity, Diabetes, and Metabolism Seminar
- Obesity medicine: a new frontierButler, PA, United States 20172017 Carol Dietrich Memorial Symposium
- Preventing childhood obesity through a mindfulness-based parenting intervention for stress reductionWashington, DC, United States 2017Obesity Week
- Lower insulin sensitivity with increasing BMI is associated with greater high-calorie food intakeWashington, DC, United States 2017Obesity Week
- Special considerations in the use of hybrid closed loopNew Haven, CT, United States 2017Hybrid Closed Loop Center of Excellence Program
- Obesity Pharmacotherapy Workshops and Meet the ExpertBoston, MA, United States 201730th Annual Blackburn Course in Obesity Medicine: Treating Obesity 2017
- Does Hyperinsulinemia in Obesity Elicit Brain Responses that Provoke Greater Motivation for Food?San Diego, CA, United States 201777th Scientific Sessions
- Obesity, Physiology and GeneticsNew York, NY, United States 2017Obesity Etiology, Prevention, and Treatment
- Special Considerations in Use of Hybrid Closed LoopNew Haven, CT, United States 2017Special Considerations in Use of Hybrid Closed Loop
- Hedonic Eating/Food Reward and Appetite Regulation and the Development of Severe Obesity in AdolescentsBethesda, MD, United States 2017Hedonic Eating/Food Reward and Appetite Regulation and the Development of Severe Obesity in Adolescents
- Obesity Medicine: A New FrontierAlbany, NY, United States 2016Innovations in Diabetes Care
- Neural Response to Glucose Ingestion in Obese AdolescentsKatowice, Silesian Voivodeship, Poland 201621st Congress
- Preventing Childhood Obesity through a Family-Based Mindfulness InterventionBethesda, MD, United States 2016Workshop on Research on Mind-Body Approaches to Improve Children's Health
- Obesity Pharmacotherapy Workshops and Meet the ExpertBoston, MA, United States 201629th Annual Blackburn Course in Obesity Medicine
- Cushing's disease: The case of whipped cream cloudsBoston, MA, United States 2016Obesity Medicine Interhospital Rounds
- AACE/ACE Comprehensive Clinical Practice Guidelines for the Medical Care of Patients with Obesity - Benefits of weight loss therapyOrlando, FL, United States 2016American Association of Clinical Endocrinologists (AACE) annual meeting
- Glucose Ingestion: Are Adolescents Different From Adults?Vancouver, BC, Canada 2015Annual meeting
- Agonism for Blocking Cocaine Euphoria and Self-AdministrationWashington, DC, United States 2015Translational Science Meeting
- Relationship between insulin resistance, brain activity, and prospective weight gainBoston, MA, United States 2015Relationship between insulin resistance, brain activity, and prospective weight gain
- Brain response to glucose ingestion: Are adolescents different from adults?San Francisco, CA, United States 201474th Scientific Sessions
- Response to Food Cues in Obese and Lean AdolescentsChicago, IL, United States 2013Annual Meeting
- Neural correlates of food-cue-induced food craving in obesity: association with insulin resistanceBethesda, MD, United States 2013NIH/NIDDK Intramural Program
- Neural Response to Food Cues and Stress in Obese IndividualsBaltimore, MD, United States 2010Neural Response to Food Cues and Stress in Obese Individuals
- Running: The Good, the Bad, and the Not So UglyBaltimore, MD, United States 2006Running: The Good, the Bad, and the Not So Ugly
- Pediatric Obesity in Old Order AmishBaltimore, MD, United States 2006Pediatric Grand Rounds
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Clinician of the Year Award, The Obesity Society | The Obesity Society | 2023 |
| American Board of Obesity Medicine (ABOM), Board of Directors (2022-2025) | ABOM | 2022 |
| Nominated for the Leonard Tow Humanism in Medicine Award Yale Teaching | Yale University | 2020 |
| NIH/NIDDK K23 Mentored Patient-Oriented Research Career Development Award | 2014 | |
| Young Physician-Scientist Award | American Association for Clinical Investigation (ASCI) | 2013 |
| First Place Poster Award, Yale Multi-Disciplinary Endocrinology & Metabolism Retreat | Yale Univeristy | 2013 |
| American Diabetes Association Young Investigator Travel Grant Award | American Diabetes Association (ADA) | 2013 |
| Burroughs Wellcome Fund Travel Award, Translational Science Meeting 2013 | Burroughs Wellcome Fund | 2013 |
| Translational Science Poster Award | Association for Clinical Research Training and Society for Clinical and Translational Science | 2013 |
| Diabetes Endocrinology Research Center (DRC), Poster Awardee | Yale University | 2011 |
| Yale Pediatric Fellows’ Research Day, Oral presentation award winner | Yale University | 2011 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Yahoo! Life | 6 types of foods and drinks to avoid when taking Ozempic or Wegovy for weight loss. https://www.yahoo.com/lifestyle/4-types-foods-avoid-taking-235144739.html | 2024 |
| Oprah Winfrey Weightwatchers Special | What Exactly IS Obesity? A Yale Doctor Explains. https://www.youtube.com/watch?v=kMI9b3_TWt0 | 2024 |
| Yale School of Medicine | New Frontiers in Obesity Research at Yale. https://medicine.yale.edu/news-article/new-frontiers-in-obesity-research-at-yale/ | 2024 |
| NBC Connecticut | What you need to know about weight loss drugs. https://www.nbcconnecticut.com/investigations/nbc-ct-responds/what-you-need-to-know-about-weight-loss-drugs/3227930/ | 2024 |
| Yale School of Medicine | Obesity Is Not a Choice: A Q&A With Ania Jastreboff. https://medicine.yale.edu/news-article/obesity-is-not-a-choice-ania-jastreboff/ | 2024 |
| Yale Insights (Youtube) | Revolution in Obesity Medication. https://www.youtube.com/watch?v=68nFKPpk_e4 | 2024 |
| News 8 WTNH | Health Headlines: What to know about muscle loss while losing weight. https://www.wtnh.com/news/health/health-headlines-what-to-know-about-muscle-loss-while-losing-weight/ | 2024 |
| Medscape | Treating Obesity: Confronting a New Normal. Ania Jastreboff, MD, PhD, associate professor of medicine Endocrinology), is one of the leading experts on a six-part series discussing the science behind the obesity epidemic. | 2023 |
| Parade | A Large New Study on Weight Loss Drugs Like Wegovy Has Good News if You’re Looking To Reduce Your Heart Attack Risk. https://www.yahoo.com/lifestyle/large-study-weight-loss-drugs-232500074.html | 2023 |
| MEDPAGE Today | And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes. https://www.medpagetoday.com/meetingcoverage/aha/107291 | 2023 |
| Healio | Semaglutide cuts cardiovascular risk by 20% in people with heart disease, obesity: SELECT. https://www.healio.com/news/cardiology/20231111/semaglutide-cuts-cardiovascular-risk-by-20-in-people-with-heart-disease-obesity-select | 2023 |
| WIRED | Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial. https://www.wired.com/story/wegovy-slashes-the-risk-of-heart-attack-and-stroke-in-a-landmark-trial/ | 2023 |
| CNBC | Novo Nordisk’s weight loss drug Wegovy slashes risk of serious heart events. https://www.cnbc.com/2023/11/11/weight-loss-drug-wegovy-slashes-risk-of-serious-heart-complications.html | 2023 |
| Time Magazine | Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows. https://time.com/6334001/weight-loss-drug-wegovy-heart-study-results/ | 2023 |
| Stat | Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound. https://www.statnews.com/2023/11/08/obesity-eli-lilly-mounjaro-zepbound-fda/ | 2023 |
| Washington Post | What to know about Zepbound, the newest weight-loss drug. https://www.washingtonpost.com/wellness/2023/11/08/what-is-mounjaro-zepbound-weight-loss-drug/ | 2023 |
| The New York Times | FDA Approves New Obesity Drug that Will Compete with Wegovy. https://www.nytimes.com/2023/11/08/health/fda-tirzepatide-obesity-zepbound-wegovy.html | 2023 |
| Medscape | Standards of Care for Obesity on Menu in Dallas? https://www.medscape.com/viewarticle/997344?src=&form=fpf | 2023 |
| The New York Times | Weight Loss Drug Cuts Risk of Heart Problem, Makers Say: https://www.nytimes.com/2023/08/08/health/wegovy-obesity-drugs-heart-disease.html | 2023 |
| The New York Times | Three factors Keeping Americans from New Weight Loss Drugs: https://www.nytimes.com/2023/08/04/health/weight-loss-drugs-obesity-wegovy-ozempic.html | 2023 |
| Medscape: Obesity Podcast | How to use new medication in clinic - https://www.medscape.com/viewarticle/982636?src= | 2023 |
| NBC News | Experimental drug could offer more weight loss than any other drug now on the market, study finds: https://www.nbcnews.com/health/health-news/experimental-drug-offer-weight-loss-drug-now-market-study-finds-rcna89702 | 2023 |
| Wall Street Journal | Ozempic: How the Diabetes Drug Works and Why It’s Such a Big Deal for Weight Loss. https://www.wsj.com/articles/ozempic-diabetes-drug-weight-loss-c0e03c25 | 2023 |
| Yale Talk with President Peter Salovey | Transforming Obesity Treatment. https://president.yale.edu/president/yale-talk/transforming-obesity-treatment | 2023 |
| Today.com | How to eat healthy if you're losing weight with Ozempic or Wegovy. https://www.today.com/health/diet-fitness/ozempic-weight-loss-healthy-diet-rcna72907 | 2023 |
| IvanHoe Broadcast News | Diabetes Drug: Can it Help People with Weight Loss? https://www.ivanhoe.com/medical-breakthroughs/weight-loss-can-diabetes-drug-help-people/ | 2023 |
| Today.com | What is 'Ozempic face'? Significant weight loss on the drug can change your face, doctors say. https://www.today.com/health/ozempic-face-rcna67737 | 2023 |
| People Magazine | Are Ozempic and Wegovy Safe? All About the Diabetes and Obesity Drugs. PEOPLE spoke with Ania Jastreboff M.D., PhD., an obesity medicine physician scientist at Yale University, to better understand the drugs and correct common misconceptions about obesity. https://people.com/health/is-wegovy-safe/ | 2023 |
| The Obesity Society | Clinical Research, Board of Governance | 2023 - Present |
| Washington Post | Weight-Loss drugs are a milestone for obesity patients but expose inequities: https://www.medscape.com/viewarticle/963276 | 2022 |
| New England Journal of Medicine (NEJM) | Four videos on obesity: pathophysiology, patients, and treatment: link to 3videos: https://www.nejm.org/doi/full/10.1056/NEJMp2214423, link to 1 video: https://www.nejm.org/doi/full/10.1056/NEJMp2215794?query=featured_home | 2022 |
| Proto: Mass General Hospital | "Prescription: Thin" https://protomag.com/clinical-research/prescription-thin/ | 2022 |
| Yale Health & Veritas Pod Cast | Ania Jastreboff: The Revolution of Obesity Medications: https://insights.som.yale.edu/insights/ania-jastreboff-the-revolution-in-obesity-medication-health-veritas-ep-50 | 2022 |
| Weight Matters Podcast | The Road Ahead: the Future of Obesity Medicine - https://www.intellihealth.co/future-of-obesity-medicine/ | 2022 |
| NBC Today | Patients seeking anti-obesity drug face ‘unprecedented’ demand, insurance hurdles. https://www.today.com/health/diet-fitness/weight-loss-wegovy-ozempic-rcna34709 | 2022 |
| Medscape TV | Not Their Fault: Obesity Warrants Long-term Management. https://www.medscape.com/viewarticle/975213 | 2022 |
| Today.com | Diabetes drug shows promise for weight loss in people with obesity. https://www.today.com/health/diet-fitness/drug-weight-loss-obesity-rcna32297 | 2022 |
| Multiple News Organizations, including CNN, NBC Today, Fox, and The Sun (UK) | “Tirzepatide once weekly for the treatment of Obesity” - Selected media related to lead authorship on NEJM publication: CNN, NBC Today, USA Today, US News, HealthDay, MedicineNet, ADA Meeting News, Nature Medicine, YaleMedicine News, Healio, NBC Right Now, Wales Online, CTV News, New York Post, MSN, diaTribe Learn, StayWell, MedPage Today, EndocrinologyNetwork, Bloomberg, the bmj, Nature Reviews Endocrinology, Fox News, CNN Instagram, Fox40, Channel 12, Medscape, CBS 58, Portland Sun, NYTV 7News, The Sun UK | 2022 |
| New York Times | Weight Loss Tied to a Dramatic Drop in Cancer Risk, New Study Shows: https://www.nytimes.com/2022/06/03/well/weight-loss-cancer.html | 2022 |
| Medscape InDiscussion Podcast | Addressing Overweight and Obesity as a Specific Target in Type 2 Diabetes with Dr. Silvio Inzucchi | 2022 |
| Weight Matters Podcast with Dr. Lou Aronne and Dr. Katherine Saunders | Guest | 2022 |
| American Association of Clinical Endocrinology (AACE) and American College of Endocrinology | Task Force Member | 2022 - Present |
| Diabetes Care | Associate Editor | 2022 - Present |
| Yale Medicine | Is It True That New Medications Treat Obesity? YM site: https://www.yalemedicine.org/news/new-medications-treat-obesity Facebook: https://www.facebook.com/YaleMed/posts/6845927352114678 Twitter: https://twitter.com/YaleMedicine/status/1472949823846367236 | 2021 |
| Medscape | The Other Epidemic: Type 2 Diabetes and Obesity: https://www.medscape.com/mtv/type-2-diabetes-s04/e02 | 2021 |
| PR Newswire | TOS Promotes National Childhood Obesity Awareness Month in September https://www.prnewswire.com/news-releases/tos-promotes-national-childhood-obesity-awareness-month-in-september-301366604.html?tc=eml_cleartime | 2021 |
| ErekaAlert! | Medically-supervised pediatric obesity treatment associated with improved psychosocial health, but access to care is limited: https://www.eurekalert.org/news-releases/925945 | 2021 |
| 45 Minutes with Professor George Grunberger | Invited expert interview with Dr. John Buse: The Role of GLP-1 analogues and SGLT2 inhibitors in treating diabetes and obesity. Czech Republic. (conducted virtually due to Covid) | 2021 |
| ErekaAlert! | The Obesity Society issues new position statement - COVID-19 vaccines are effective in people with obesity: https://www.eurekalert.org/pub_releases/2021-07/tos-tos070621.php | 2021 |
| JAMA Network | Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment: https://jamanetwork.com/journals/jama/fullarticle/2781520 | 2021 |
| Obesity - National Childhood Obesity Awareness Month Special Issue | Associate Editor | 2021 - Present |
| Medscape | Ongoing Semaglutide Treatment Extends Weight Loss in STEP 4: https://www.medscape.com/viewarticle/948293 | 2021 |
| Healio Endocrinology | COVID-19 hospitalization, death risk rise ‘sharply’ with BMI – Perspective: https://www.healio.com/news/endocrinology/20210505/covid19-hospitalization-death-risk-rise-sharply-with-bmi | 2021 |
| Connecticut General Assembly | Provided expert testimony before the Connecticut General Assembly’s in support of Senate Bill 1007, a bill which would require Medicaid and private insurers to cover bariatric surgery and FDA-approved medications for individuals with a BMI of >40 kg/m2. | 2021 |
| The Obesity Society | Clinical Care Committee | 2021 - 2023 |
| NIH Study Section: Optimizing therapy for hypothalmic obesity by developing a personalized, adaptive intervention | Reviewer | 2021 |
| The Obesity Society | TOS Pediatric Obesity Treatment Task Force | 2021 - Present |
| The Healthy | 11 Healthy Late-Night Snacks Nutritionists Actually Recommend https://www.thehealthy.com/nutrition/healthy-late-night-snacks | 2020 |
| Healio Endocrinology | Mild Obesity doubles risk for respiratory failure in COVID-19 https://www.healio.com/news/endocrinology/20200716/mild-obesity-doubles-risk-for-respiratory-failure-in-covid19 | 2020 |
| WNPR Radio Podcast | Yale Cancer Answers podcast: Obesity and Breast Cancer (Pod Cast interview): https://www.yalecancercenter.org/patient/answers/programs/ | 2020 |
| News 12 Connecticut | Physician recommends keeping weight under control during respiratory pandemic: http://connecticut.news12.com/story/42185767/physician-recommends-keeping-weight-under-control-during-respiratory-pandemic | 2020 |
| WTNH (Channel 8) | WTNH (Channel 8) On Call: Keto Diet – TV interview on news station: https://www.wtnh.com/news/health/news-8-on-call-keto-diet/ | 2020 |
| WTNH (Channel 8) | WTNH (Channel 8). Top 3 dieting trends of 2020. Live TV interview on news station: https://www.wtnh.com/on-air/gmct-at-nine/top-3-dieting-trends-of-2020/ | 2020 |
| Yale Center for Clinical Investigation | Scholar Award Grant Reviewer | 2020 |
| NIH Study Section: Physiology of the weight-reduced state | Reviewer | 2020 |
| Better Health | Better Health. 12 diets you should never try, according to health experts. https://www.eatthis.com/unhealthiest-diets-experts/ | 2019 |
| Better Health | Better Health. Healthy gifts that are doctor recommended. https://www.eatthis.com/healthy-gifts/ | 2019 |
| WTNH (Channel 8) | WTNH (Channel 8) On Call: New policy for children with severe obesity – TV interview on news station: https://www.wtnh.com/lifestyle/health-news/news-8-on-call-new-policy-for-children-with-severe-obesity/ | 2019 |
| Huffington Post | Huffington Post. This is your body on Keto. https://www.huffpost.com/entry/keto-effects-body_l_5d9b58abe4b099389803e441 | 2019 |
| Health Central | Health Central. When diet and exercise aren’t enough. https://www.healthcentral.com/article/obesity-treatments | 2019 |
| WTNH (Channel 8) | WTNH (Channel 8) Dealing with Diabetes on Campus – Live TV interview on news station: https://www.wtnh.com/on-air/dealing-with-diabetes-on-campus/ | 2019 |
| ADA (American Diabetes Association) | Obesity/Pathogenesis of Obesity Subcommittee | 2019 - Present |
| The Obesity Society | Clinical Committee | 2019 - 2021 |
| American Diabetes Association | Research Grant Review Committee, ADA Core Research Program | 2019 - 2020 |
| NIH Study Section: KNOD - Kidney, Nutrition, Obesity and Diabetes | NIH Study Section ad hoc reviewer KNOD: Kidney, Nutrition, Obesity, and Diabetes | 2019 |
| The Endocrine Society | Hormone Health Network (HHN) committee | 2019 - Present |
| NPR | National Public Radio (NPR) live interview on Where We Live with David Deroches and Lydia Brown: America’s Diet Craving. http://www.wnpr.org/post/americas-diet-craving | 2018 |
| MedPage Today | MedPage Today: Progress in Type 2 Diabetes Care – interview (videos): (1) Treating the Root Cause: Obesity Medicine: https://www.medpagetoday.com/resource-centers/progress-in-type-2-diabetes-care/obesity-medicine/19 (2) How Effective is Weight Loss as Therapy for Type 2 Diabetes? https://www.medpagetoday.com/resource-centers/progress-in-type-2-diabetes-care/weight-loss-as-therapy-for-type-2-diabetes/3 (3) Diets in Diabetes: One Size Doesn’t Fit All: ): https://www.medpagetoday.com/resource-centers/progress-in-type-2-diabetes-care/diet-in-diabetes/22 (4) Beating the Set Point and Maintaining Weight Loss: https://www.medpagetoday.com/resource-centers/progress-in-type-2-diabetes-care/maintaining-weight-loss/20 (5) Potential Risks of Anti-obesity Medications in Patients with T2D: https://www.medpagetoday.com/resource-centers/progress-in-type-2-diabetes-care/potential-risks-of-anti-obesity-medications/21 | 2017 |
| Department of Chronic Disease Epidemiology | Faculty Search Committee | 2017 - 2018 |
| American Association of Clinical Endocrinology (AACE) and American College of Endocrinology | AACE 2nd Consensus Conference on Obesity Writing Task Force | 2017 - 2018 |
| NIH Study Section: PRDP: Psychosocial Risk and Disease Prevention | NIH Study Section ad hoc reviewer PRDP: Psychosocial Risk and Disease Prevention | 2017 |
| The Obesity Society | Grant Reviewer (Scientific Review Committee) | 2017 - Present |
| The Obesity Society | co-chair neuroimaging program planning committee 2019-2020, committee member 2016-present | 2016 - 2020 |
| Yale Medicine | Yale Medicine: Why Obesity is a Disease – interview (video) Obesity is a growing epidemic in America. Ania Jastreboff, MD, PhD discusses why obesity is a disease with biological underpinnings. In addition, she discusses treatment options and medications. https://www.yalemedicine.org/conditions/why-obesity-is-a-disease/ | 2016 |
| The Obesity Society | Obesity Medicine Fellowship Curriculum Development Committee | 2015 - 2016 |
| The Obesity Society | Development of "Contributors to Obesity" infographic for organizational use and the Surgeon General (Committee) | 2015 |
| American Association of Clinical Endocrinology (AACE) and American College of Endocrinology | Task Force for the Obesity Algorithm | 2015 - 2016 |
| American Association of Clinical Endocrinology (AACE) and American College of Endocrinology | Task Force for the development of Clinical Practice Guidelines for the Comprehensive Medical Care of Patients with Obesity | 2015 - 2016 |
| Internal Medicine News | Glucose lights up the adolescent brain. http://www.internalmedicinenews.com/home/article/glucose-lights-up-the-adolescent-brain/e5eb5207198ba22d6ddbc398c9fa6cff.html | 2014 |
| ADA Scientific Sessions Clinical Endocrinology News - video interview | Teen Brain Reacts to Sugar Differently. http://www.clinicalendocrinologynews.com/home/article/video-teen-brain-reacts-to-sugar-differently/98bf5dc38738d15c5068bfbb0afb3b57.html | 2014 |
| Z-News | Adolescents' Brains Process Sugar Differently Than Adults: Study. http://zeenews.india.com/news/health/health-news/adolescents-brains-process-sugar-differently-than-adults-study_28440.html | 2014 |
| Market Watch | Understanding the unique nature of children's bodies and brains. http://www.marketwatch.comn/story/understanding-the-unique-nature-of-childrens-bodies-and-brains-20014-06-15 | 2014 |
| The Hindu Business Line | Sugar Affects Brain of Teens, Adults Differently. http://www.thehindubusinessline.com/news/sugar-affects-brains-of-teens-adults-differently/article6120018.ece | 2014 |
| Medical Daily | Studies attempt to explain the onset of obesity and diabetes in children and adolescents. http://www.medicaldaily.com/studies-attempt-explain-onset-obesity-and-diabetes-children-and-adolescents-28830 | 2014 |
| American Diabetes Association (ADA) | Member | 2008 - Present |
Departments & Organizations
- Center for Weight Management
- Diabetes Center
- Diabetes Program
- Diabetes Research Center
- Endocrinology
- Internal Medicine
- Obesity Research Working Group
- Pediatric Weight Solutions Program
- Status of Women in Medicine Committee (SWIM)
- Yale Medicine
- Yale Obesity Research Center (Y-Weight)
- Yale Stress Center